↓ Skip to main content

Dove Medical Press

Advances in the management of relapsing–remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)

Overview of attention for article published in Degenerative Neurological and Neuromuscular Disease, May 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
6 Mendeley
Title
Advances in the management of relapsing–remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)
Published in
Degenerative Neurological and Neuromuscular Disease, May 2015
DOI 10.2147/dnnd.s68723
Pubmed ID
Authors

A Scott Nielsen

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 17%
Researcher 1 17%
Other 1 17%
Student > Master 1 17%
Unknown 2 33%
Readers by discipline Count As %
Chemistry 1 17%
Medicine and Dentistry 1 17%
Unknown 4 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2015.
All research outputs
#17,438,425
of 25,584,565 outputs
Outputs from Degenerative Neurological and Neuromuscular Disease
#59
of 89 outputs
Outputs of similar age
#169,644
of 279,338 outputs
Outputs of similar age from Degenerative Neurological and Neuromuscular Disease
#1
of 1 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 89 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,338 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them